Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Saturday 14 May 2016 3:34 pm

Pfizer bans its drugs from use in lethal injections

By: James Nickerson

Add as a preferred source on Google

Pfizer has become the latest pharmaceutical company to ban its drugs from use in lethal injections.

The company is the last major drugs maker to ban its drugs in the use of capital punishment, meaning the open market for drugs is closed to states which still execute people.

The decision has called into question the viability of the death penalty in some American states.

Read more: City PM Unregulated: Episode 1 – Panama Papers, Pfizer and Allergan

"Pfizer makes its products to enhance and save the lives of the patients we serve. Consistent with these values, Pfizer strongly objects to the use of its products as lethal injections for capital punishment," the pharma giant said.

The company will only sale to wholesalers who sign contracts that commits them not to sell them to state authorities for the use of executions.

All 25 drug companies approved by the US Food and Drug Administration have blocked their products in capital punishment, says human rights group Repreive.

"Pfizer's actions cement the pharmaceutical industry's opposition to the misuse of medicines," Maya Foa, its director, said

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Trending Articles

  • Exclusive: Big Four giant KPMG to cut more jobs

  • Music tycoon Simon Cowell sued by prominent City lawyer

  • The former African gold miner taking on the billionaire Issa brothers

  • Tesco ‘in talks’ to exit eastern Europe

  • Easyjet agrees to £5.7bn Apollo takeover

More from City PM

  • Regulator wins decade-long pricing tussle with Pfizer

    Legal
    Hikma reported a jump in profit for 2024
  • NIKE, Inc. Announces Planned CFO Transition

    Business Wire
  • Terry Smith dubs weight-loss giant Novo Nordisk ‘investment disaster’

    Investing
    Terry Smith, founder of Fundsmith, speaking at a business conference, wearing a suit and tie, with a focused expression.
  • Curatis Increases Revenue Growth Guidance for 2026

    Business Wire
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • LivaNova Appoints Anne Liddy as Chief Legal Officer

    Business Wire
  • Alphabet to join Dow Jones in rare index reshuffle

    Tech
    Googles modern Kings Cross headquarters showcasing innovative architecture in Londons dynamic tech district
  • UK defence chief: Adopt AI or lose future wars

    Tech
    UK defence strategy meeting, officials discussing military advancements and security measures in a conference room setting

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook